Page 198 - Read Online
P. 198

Page 426                                             Saneto. J Transl Genet Genom 2020;4:384-428  I  http://dx.doi.org/10.20517/jtgg.2020.40

               299. Marce-Grau A, Marti-Sanchez L, Baide-Mairena H, Ortigoza-Escobar JD, Perez-Duenas B. Genetic defects of thiamine transport and
                   metabolism: a review of clinical phenotypes, genetics, and functional studies. J Inherit Metab Dis 2019;42:581-97.
               300. Bottega R, Perrone MD, Vecchiato K, Taddio A, Sabui S, et al. Functional analysis of the third identified SLC25A19 mutation causative
                   for thiamine metabolism dysfunction syndrome 4. J Hum Genet 2019;64:1075-81.
               301. Maid H, King MS, Smith AC, Kunji ERS. Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 impaired citrate
                   export required for lipid, dolichol, ubiquinone and sterol synthesis. Biochim Biophys Acta Bioenerg 2018;1859:1-7.
               302. Boulet A, Vest KE, Maynard MK, Gammon MG, Russell AC, et al. The mammalian phosphate carrier SLC25A3 is a mitochondrial
                   copper transporter required for cytochrome c oxidase biogenesis. J Biol Chem 2018;293:1887-96.
               303. Mayr JA, Zimmermann FA, Horvath R, Schneider HC, Schoser B, et al. Deficiency of the mitochondrial phosphate carrier presenting as
                   myopathy and cardiomyopathy in a family with three affected children. Neuromuscul Disord 2011;21:803-8.
               304. von Renesse A, Morales-Gonzalez S, Gill E, Salomons GS, Stenzel W, et al. Muscle weakness, cardiomyopathy and L-2-hydroxyglutaric
                   aciduria associated with a novel recessive SLC25A4 mutation. JIMD Rep 2019;43:27-35.
               305. Thompson K, Majd H, Dallabona C, Reinson K, King MS, et al. Recurrent de novo dominant mutations in SLC25A4 cause severe early
                   onset mitochondrial disease and loss of mitochondrial DNA copy number. Am J Hum Genet 2016;99:860-76.
               306. Punzi G, Porcelli V, Ruggiu M, Hossain MF, Menga A, et al. SLC25A10 biallelic mutations in intractable epileptic encephalopathy with
                   complex I deficiency. Hum Mol Genet 2018;27:499-504.
               307. Falk MJ, Li D, Gai X, McCormick E, Place E, et al. AGC1 deficiency causes infantile epilepsy, abnormal myelination, and reduced
                   N-acetylaspartate. JIMD Rep 2014;14:77-85.
               308. Wiborm R, Lasorsa FM, Tohonen V, Barbaro M, Sterky FH, et al. AGC1 deficiency associated with global cerebral hypomyelination.
                   New Engl J Med 2009;361:489-95.
               309. Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia
                   (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet 2002;47:333-41.
               310. Camacho JA, Obie C, Biery B, Goodman BK, Hu CA, et al. Hyperornithinemia-syndrome is caused by mutations in a gene encoding a
                   mitochondrial ornithine transporter. Nat Genet 1999;22:151-8.
               311.  Khan S, Ansar M, Khan AK, Shah K, Muhammad N, et al. A homozygous missense mutation in SLC25A16 is associated with autosomal
                   recessive isolated fingernail dysplasia in a Pakistani family. Br J Dermatol 2018;178:556-8.
               312. Lopriore E, Gemke RJ, Verhoeven NM, Jakobs C, Wanders RJ, et al. Carnitine-acylcarnitine translocase deficiency: phenotype, residual
                   enzyme activity and outcome. Eur J Pediatr 2001;160:101-4.
               313. Iacobazzi V, Invernizzi F, Baratta S, Pons R, Chung W, et al. Molecular and functional analysis of SLC25A20 mutations causing
                   carnitine-acylcarnitine translocase deficiency. Hum Mutat 2004;24:312-20.
               314. Boczonadi V, King MS, Smith AC, Olahova M, Bansagi B, et al. Mitochondrial oxodicarboxylated carrier deficiency is associated with
                   mitochondrial depletion and spinal muscular atrophy-like disease. Genet Med 2018;20:1224-35.
               315. Fiermonte G, Palmieri L, Todisco S, Agrimi G, Palmieri F, et al. Identification of the mitochondrial glutamate transporter. Bacterial
                   expression, reconstitution, functional characterization and tissue distribution of two human isoforms. J Biol Chem 2002;277:19289-94.
               316. Molinari F, Raas-Rothschild A, Rio M, Fiermonte G, Encha-Razavi F, et al. Impaired mitochondrial glutamate transport in autosomal
                   recessive neonatal myoclonic epilepsy. Am J Hum Genet 2005;76:334-9.
               317. Cohen R, Basel-Vanagaite L, Goldberg-Stern H, Halevy A, Shuper A, et al. Two siblings with early infantile myoclonic encephalopathy
                   due to mutation in the gene encoding mitochondrial glutamate/H+ symporter SLC25A22. Eur J Paediatr Neurol 2014;18:801-5.
               318. Fiermonte G, De Leonardis F, Todisco S, Palmieri L, Lasorsa RM, et al. Identification of the mitochondrial ATP-Mg/Pi transporter.
                   Bacterial expression, reconstitution, functional characterization, and tissue distribution of two human isoforms. J Biol Chem
                   2004;279:30722-30.
               319. Writzl K, Maver A, Kovacic L, Martinex-Valero P, Contreras L, et al. De novo mutations in SLC25A24 cause a disorder characterized by
                   early aging, bone dysplasia, characteristic face, and early demise. Am J Hum Genet 2017;101:844-55.
               320. Kishita Y, Pajak A, Bolar NA, Marobbio CMT, Maffezzini C, et al. Intra-mitochondrial methylation deficiency due to mutations in
                   SLC25A26. Am J Hum Genet 2015;97:761-8.
               321. Spaan AN, Ijlst L, van Roermund CW, Wijburg FA, Wanders RJ, et al. Identification of the human FAD transporter and its potential role
                   in multiple acyl-CoA dehydrogenase deficiency. Mol Genet Metab 2005;86:441-7.
               322. Hellebrekers DMEI, Sallevelt SCEH, Theunissen TEJ, Hendricks ATM, Gottschalk RW, et al. Novel SLCA2532 mutation in a patient
                   with a severe neuromuscular phenotype. Eur J Hum Genet 2017;25:886-8.
               323. Guernsey DL, Jiang H, Campagna DR, Evans SC, Ferguson M, et al. Mutations in mitochondrial carrier family gene SLC25A38 cause
                   nonsyndromic autosomal recessive congenital sideroblastic anemia. Nature Genet 2009;42:651-3.
               324. Wan J, Steffen J, Yourshaw M, Mamsa H, Andersen E, et al. Loss of function of SLC25A46 causes lethal congenital pontocerebellar
                   hypoplasia. Brain 2016;139:2877-90.
               325. Abrams AJ, Fontanesi F, Tan NBL, Buglo E, Campeanu IJ, et al. Insights into the genotype-phenotype correlation and molecular function
                   of LSC25A46. Hum Mutat 2018;39:1995-2007.
               326. Sancak Y, Markhard AL, Kitami T, Kovacs-Bodgan E, Kamer KJ, et al. EMRE is an essential component of the mitochondrial calcium
                   uniporter complex. Science 2013;342:1379-82.
               327. Kamer KJ, Grabarek Z, Mootha VK. High-affinity cooperative Ca2+ binding by MICU1-MICU2 serves as an on-off switch for the
                   uniporter. EMBO Reports 2017;18:1397-411.
               328. Musa S, Eyaid W, Kamer K, Ali R, Al-Mureikhi M, et al. A middle eastern founder mutation expands the genotypic and phenotypic
   193   194   195   196   197   198   199   200   201   202   203